...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Complement dependent cytotoxicity (CDC) activity of a humanized anti Lewis-Y antibody: FACS-based assay versus the 'classical' radioactive method -- qualification, comparison and application of the FACS-based approach.
【24h】

Complement dependent cytotoxicity (CDC) activity of a humanized anti Lewis-Y antibody: FACS-based assay versus the 'classical' radioactive method -- qualification, comparison and application of the FACS-based approach.

机译:人源化抗Lewis-Y抗体的补体依赖性细胞毒性(CDC)活性:基于FACS的测定法与``经典''放射性方法-基于FACS的方法的鉴定,比较和应用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The fully humanized Lewis-Y carbohydrate specific monoclonal antibody (mAb) IGN311 is currently tested in a passive immunotherapy approach in a clinical phase I trail and therefore regulatory requirements demand qualified assays for product analysis. To demonstrate the functionality of its Fc-region, the capacity of IGN311 to mediate complement dependent cytotoxicity (CDC) against human breast cancer cells was evaluated. The "classical" radioactive method using chromium-51 and a FACS-based assay were established and qualified according to ICH guidelines. Parameters evaluated were specificity, response function, bias, repeatability (intra-day precision), intermediate precision (operator-time different), and linearity (assay range). In the course of a fully nested design, a four-parameter logistic equation was identified as appropriate calibration model for both methods. For the radioactive assay, the bias ranged from -6.1% to -3.6%. The intermediate precision for future means of duplicate measurements revealed values from 12.5% to 15.9% and the total error (beta-expectation tolerance interval) of the method was found to be <40%. For the FACS-based assay, the bias ranged from -8.3% to 0.6% and the intermediate precision for future means of duplicate measurements revealed values from 4.2% to 8.0%. The total error of the method was found to be <25%. The presented data demonstrate that the FACS-based CDC is more accurate than the radioactive assay. Also, the elimination of radioactivity and the 'real-time' counting of apoptotic cells further justifies the implementation of this method which was subsequently applied for testing the influence of storage at 4 degrees C and 25 degrees C ('stability testing') on the potency of IGN311 drug product. The obtained results demonstrate that the qualified functional assay represents a stability indicating test method.
机译:完全人源化的Lewis-Y碳水化合物特异性单克隆抗体(mAb)IGN311目前已在I期临床试验中采用被动免疫疗法进行了测试,因此法规要求要求对产品进行合格的分析。为了证明其Fc区的功能,评估了IGN311介导针对人乳腺癌细胞的补体依赖性细胞毒性(CDC)的能力。建立了使用铬51的“经典”放射性方法和基于FACS的测定方法,并根据ICH指南进行了鉴定。评估的参数是特异性,响应函数,偏倚,可重复性(日内精度),中间精度(操作者时间不同)和线性(测定范围)。在完全嵌套的设计过程中,确定了四参数对数方程作为这两种方法的适当校准模型。对于放射性测定,偏差范围为-6.1%至-3.6%。未来重复测量手段的中间精度显示该值在12.5%至15.9%之间,并且该方法的总误差(β期望容差区间)小于40%。对于基于FACS的测定,偏差范围为-8.3%至0.6%,并且将来进行重复测量的中间精度为4.2%至8.0%。发现该方法的总误差小于25%。所提供的数据表明,基于FACS的CDC比放射性分析更为准确。同样,消除放射性和凋亡细胞的“实时”计数进一步证明了该方法的实施,该方法随后被用于测试4摄氏度和25摄氏度下储存对细胞的影响(“稳定性测试”)。 IGN311药品的效力。获得的结果表明合格的功能测定代表了稳定性指示测试方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号